Cargando…
A straightforward method to quantify circulating mRNAs as biomarkers of colorectal cancer
Optimizing the biomarker combination to be analyzed in liquid biopsies should improve personalized medicine. We developed a method to purify circulating cell-free mRNAs from plasma samples and to quantify them by RT-qPCR. We selected three candidate colorectal cancer biomarkers (B2M, TIMP-1, and CLU...
Autores principales: | Grosgeorges, Marie, Picque Lasorsa, Laurence, Pastor, Brice, Prévostel, Corinne, Crapez, Evelyne, Sanchez, Cynthia, Frayssinoux, Florence, Jarlier, Marta, Pezzella, Véronique, Monard, Laure, Ychou, Marc, Thierry, Alain R., Mazard, Thibault, Blache, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932139/ https://www.ncbi.nlm.nih.gov/pubmed/36792801 http://dx.doi.org/10.1038/s41598-023-29948-4 |
Ejemplares similares
-
Modulating PKCα Activity to Target Wnt/β-Catenin Signaling in Colon Cancer
por: Dupasquier, Sébastien, et al.
Publicado: (2019) -
SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling
por: Prévostel, Corinne, et al.
Publicado: (2016) -
Association of neutrophil extracellular traps with the production of circulating DNA in patients with colorectal cancer
por: Pastor, Brice, et al.
Publicado: (2022) -
Comparison of the structures and topologies of plasma extracted circulating nuclear and mitochondrial cell-free DNA
por: Pisareva, Ekaterina, et al.
Publicado: (2023) -
FOLFIRINOX-R study design: a phase I/II trial of FOLFIRINOX plus regorafenib as first line therapy in patients with unresectable RAS-mutated metastatic colorectal cancer
por: Adenis, Antoine, et al.
Publicado: (2021)